• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型2-芳基噻唑烷-4-酮衍生物的设计、合成及抗菌活性评价

Design, synthesis and antimicrobial evaluation of novel 2-aryl-thiazolidin-4-one derivatives.

作者信息

Prasad Davinder, Kumar Awanit, Shukla Praveen Kumar, Nath Mahendra

机构信息

Department of Chemistry, University of Delhi, Delhi 110 007, India.

出版信息

Org Med Chem Lett. 2011 Aug 3;1(1):4. doi: 10.1186/2191-2858-1-4.

DOI:10.1186/2191-2858-1-4
PMID:22373323
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3279145/
Abstract

Novel 2-arylthiazolidin-4-one derivatives (8a-q and 11) have been synthesized in good-to-excellent yields (70-96%) by one-pot three-component condensation-cyclization reaction of aromatic or aliphatic primary amines, aromatic aldehydes, and thioglycolic acid in polypropylene glycol at 110°C temperature. The in vitro antimicrobial activity of the synthesized 2-arylthiazolidin-4-ones was investigated against a panel of six pathogenic fungal strains, a Gram-positive and three Gram-negative bacteria. Results revealed that the compounds (8a-d) bearing 3-(4-(1H-imidazolylmethyl)phenyl)-substituent displayed significant antibacterial efficacy specifically against Klebsiella pneumoniae (minimum inhibitory concentration 12.5 μg/mL). In addition, some of the synthesized compounds have also shown antimicotic activity against Sporothrix schenckii, Trichophyton mentagrophytes, and Aspergillus fumigatus at the concentration of 50 μg/mL.

摘要

通过在110°C温度下,使芳香族或脂肪族伯胺、芳香醛和巯基乙酸在聚丙二醇中进行一锅三组分缩合环化反应,已以良好至优异的产率(70 - 96%)合成了新型2-芳基噻唑烷-4-酮衍生物(8a - q和11)。研究了合成的2-芳基噻唑烷-4-酮对一组六种致病真菌菌株、一种革兰氏阳性菌和三种革兰氏阴性菌的体外抗菌活性。结果表明,带有3-(4-(1H-咪唑基甲基)phenyl)-取代基的化合物(8a - d)对肺炎克雷伯菌显示出显著的抗菌效果(最低抑菌浓度为12.5 μg/mL)。此外,一些合成化合物在50 μg/mL的浓度下对申克孢子丝菌、须癣毛癣菌和烟曲霉也表现出抗真菌活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6896/3279145/1242b237cd81/2191-2858-1-4-i3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6896/3279145/fa33cb0ba3c2/2191-2858-1-4-i1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6896/3279145/68ea791a09c6/2191-2858-1-4-i2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6896/3279145/1242b237cd81/2191-2858-1-4-i3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6896/3279145/fa33cb0ba3c2/2191-2858-1-4-i1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6896/3279145/68ea791a09c6/2191-2858-1-4-i2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6896/3279145/1242b237cd81/2191-2858-1-4-i3.jpg

相似文献

1
Design, synthesis and antimicrobial evaluation of novel 2-aryl-thiazolidin-4-one derivatives.新型2-芳基噻唑烷-4-酮衍生物的设计、合成及抗菌活性评价
Org Med Chem Lett. 2011 Aug 3;1(1):4. doi: 10.1186/2191-2858-1-4.
2
Antimicrobial and cytotoxic activities of isoniazid connected menthone derivatives and their investigation of clinical pathogens causing infectious disease.异烟肼连接的薄荷酮衍生物的抗菌和细胞毒性活性及其对引起传染病的临床病原体的研究。
J Infect Public Health. 2021 Apr;14(4):533-542. doi: 10.1016/j.jiph.2020.12.033. Epub 2021 Feb 6.
3
Synthesis, Characterization, Antibacterial and Antioxidant Potency of NSubstituted- 2-Sulfanylidene-1,3-Thiazolidin-4-one Derivatives and QSAR Study.N-取代-2-硫代亚甲基-1,3-噻唑烷-4-酮衍生物的合成、表征、抗菌和抗氧化活性及 QSAR 研究。
Med Chem. 2019;15(8):840-849. doi: 10.2174/1573406415666181205163052.
4
Synthesis and Pharmacological Evaluation of Azetidin-2-ones and Thiazolidin-4-ones Encompassing Benzothiazole.含苯并噻唑的氮杂环丁烷-2-酮和噻唑烷-4-酮的合成及药理评价
Indian J Pharm Sci. 2008 Sep;70(5):572-7. doi: 10.4103/0250-474X.45393.
5
Synthesis, Antimicrobial, and Anti-Proliferative Activities of Novel 4-(Adamantan-1-yl)-1-arylidene-3-thiosemicarbazides, 4-Arylmethyl '-(Adamantan-1-yl)piperidine-1-carbothioimidates, and Related Derivatives.新型 4-(金刚烷-1-基)-1-芳基亚甲基-3-硫代缩氨脲、4-芳基甲基 '-(金刚烷-1-基)哌啶-1-碳硫代亚氨代酯及其相关衍生物的合成、抗菌和抗增殖活性。
Molecules. 2019 Nov 26;24(23):4308. doi: 10.3390/molecules24234308.
6
Quaternized N-substituted carboxymethyl chitosan derivatives as antimicrobial agents.季铵化 N-取代羧甲基壳聚糖衍生物作为抗菌剂。
Int J Biol Macromol. 2013 Sep;60:156-64. doi: 10.1016/j.ijbiomac.2013.05.022. Epub 2013 May 31.
7
Antimicrobial Activity of New 2-Thioxo-benzo[g]quinazolin-4(3H)-one Derivatives.新型2-硫代苯并[g]喹唑啉-4(3H)-酮衍生物的抗菌活性
Med Chem. 2016;13(1):85-92. doi: 10.2174/1573406412666160610095706.
8
Novel Synthesis of 4-Benzylidene-2-((1-phenyl-3,4-dihydroisoquinoline-2(1H)-yl)methyl) oxazol-5(4H)-one Derivatives Using 1,2,3,Tetrahydroisoquinoline and their Antimicrobial Activity.新型 4-苄叉基-2-((1-苯基-3,4-二氢异喹啉-2(1H)-基)甲基)恶唑啉-5(4H)-酮衍生物的合成及抗菌活性研究。
Curr Org Synth. 2020;17(5):396-403. doi: 10.2174/1570179417666200415151228.
9
Synthesis and antimicrobial study of linked heterocyclics containing Pyrazole-pyrimidine-thiazolidin-4-one.含吡唑-嘧啶-噻唑烷-4-酮的连接杂环化合物的合成与抗菌研究
Chem Pharm Bull (Tokyo). 2010 Dec;58(12):1622-6. doi: 10.1248/cpb.58.1622.
10
In vitro evaluation of new 2-phenoxy-benzo[g][1,2,4]triazolo[1,5-a]quinazoline derivatives as antimicrobial agents.新型 2-苯氧基苯并[g][1,2,4]三唑并[1,5-a]喹唑啉衍生物的体外抗菌活性评价。
Microb Pathog. 2018 Apr;117:60-67. doi: 10.1016/j.micpath.2018.02.018. Epub 2018 Feb 9.

引用本文的文献

1
Recent advances in synthetic strategies and SAR of thiazolidin-4-one containing molecules in cancer therapeutics.含噻唑烷-4-酮结构的分子在癌症治疗中的合成策略和 SAR 的最新进展。
Cancer Metastasis Rev. 2023 Sep;42(3):847-889. doi: 10.1007/s10555-023-10106-1. Epub 2023 May 19.
2
Design, synthesis, in silico studies and biological evaluation of 5-(()-4-(()-(substituted aryl/alkyl)methyl)benzylidene)thiazolidine-2,4-dione derivatives.5-(()-4-(()-(取代芳基/烷基)甲基)亚苄基)噻唑烷-2,4-二酮衍生物的设计、合成、计算机模拟研究及生物学评价
BMC Chem. 2020 Mar 31;14(1):25. doi: 10.1186/s13065-020-00678-2. eCollection 2020 Dec.
3

本文引用的文献

1
Synthesis, biological evaluation, and molecular modeling of 1-benzyl-1H-imidazoles as selective inhibitors of aldosterone synthase (CYP11B2).1-苄基-1H-咪唑类化合物的合成、生物评价及作为醛固酮合酶(CYP11B2)选择性抑制剂的分子模拟。
J Med Chem. 2010 Feb 25;53(4):1712-25. doi: 10.1021/jm901356d.
2
An eco-friendly synthesis and antimicrobial activities of dihydro-2H-benzo- and naphtho-1,3-oxazine derivatives.二氢苯并[1,3]氧嗪和萘并[1,3]氧嗪衍生物的环保合成及抗菌活性。
Eur J Med Chem. 2010 Apr;45(4):1502-7. doi: 10.1016/j.ejmech.2009.12.058. Epub 2010 Jan 13.
3
Novel 4-thiazolidinone derivatives as potential antifungal and antibacterial drugs.
The synthesis and the biological evaluation of new thiazolidin-4-one derivatives containing a xanthine moiety.
含黄嘌呤部分的新型噻唑烷-4-酮衍生物的合成与生物评价。
Molecules. 2013 Aug 13;18(8):9684-703. doi: 10.3390/molecules18089684.
新型 4-噻唑烷酮衍生物作为有潜力的抗真菌和抗菌药物。
Bioorg Med Chem. 2010 Jan 1;18(1):426-32. doi: 10.1016/j.bmc.2009.10.041. Epub 2009 Oct 27.
4
Recent approaches to antifungal therapy for invasive mycoses.侵袭性真菌病抗真菌治疗的最新方法。
ChemMedChem. 2009 Mar;4(3):310-23. doi: 10.1002/cmdc.200800353.
5
Synthesis and evaluation of 2-(2,6-dihalophenyl)-3-pyrimidinyl-1,3-thiazolidin-4-one analogues as anti-HIV-1 agents.2-(2,6-二卤苯基)-3-嘧啶基-1,3-噻唑烷-4-酮类似物作为抗HIV-1药物的合成与评价
Bioorg Med Chem. 2007 May 1;15(9):3134-42. doi: 10.1016/j.bmc.2007.02.044. Epub 2007 Feb 23.
6
Synthesis and antimicrobial activity of novel 2-thiazolylimino-5-arylidene-4-thiazolidinones.新型2-噻唑基亚氨基-5-亚芳基-4-噻唑烷酮的合成与抗菌活性
Bioorg Med Chem. 2006 Jun 1;14(11):3859-64. doi: 10.1016/j.bmc.2006.01.043. Epub 2006 Feb 20.
7
European status of resistance in nosocomial infections.欧洲医院感染中的耐药状况。
Chemotherapy. 2005 Jul;51(4):177-81. doi: 10.1159/000086919. Epub 2005 Jul 6.
8
Chiral 3,3'-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4-thiazolidinones] with anti-inflammatory activity. Part 11: evaluation of COX-2 selectivity and modelling.具有抗炎活性的手性3,3'-(1,2-亚乙基)-双[2-(3,4-二甲氧基苯基)-4-噻唑烷酮]。第11部分:COX-2选择性评估与建模。
Bioorg Med Chem. 2003 Mar 20;11(6):999-1006. doi: 10.1016/s0968-0896(02)00518-7.
9
Synthesis and serotonergic activity of N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine and analogues: potent agonists for 5-HT1D receptors.
J Med Chem. 1995 May 12;38(10):1799-810. doi: 10.1021/jm00010a025.
10
Substituted thiazolidones as anticonvulsants.
J Med Chem. 1972 May;15(5):553-4. doi: 10.1021/jm00275a031.